Cited by 349Microbial Metabolites in Food BiotechnologyGut microbiota and healthProbiotics and Fermented Foods

A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults

Open access
Vulevic, Jelena, Juric, Aleksandra, Tzortzis, George, Gibson, Glenn R.·2013·The Journal of Nutrition

Abstract

Metabolic syndrome is a set of disorders that increases the risk of developing cardiovascular disease. The gut microbiota is altered toward a less beneficial composition in overweight adults and this change can be accompanied by inflammation. Prebiotics such as galactooligosaccharides can positively modify the gut microbiota and immune system; some may also reduce blood lipids. We assessed the effect of a galactooligosaccharide mixture [Bi2muno (B-GOS)] on markers of metabolic syndrome, gut microbiota, and immune function in 45 overweight adults with ≥3 risk factors associated with metabolic syndrome in a double-blind, randomized, placebo (maltodextrin)-controlled, crossover study (with a 4-wk wash-out period between interventions). Whole blood, saliva, feces, and anthropometric measurements were taken at the beginning, wk 6, and end of each 12-wk intervention period. Predominant groups of fecal bacteria were quantified and full blood count, markers of inflammation and lipid metabolism, insulin, and glucose were measured. B-GOS increased the number of fecal bifidobacteria at the expense of less desirable groups of bacteria. Increases in fecal secretory IgA and decreases in fecal calprotectin, plasma C-reactive protein, insulin, total cholesterol (TC), TG, and the TC:HDL cholesterol ratio were also observed. Administration of B-GOS to overweight adults resulted in positive effects on the composition of the gut microbiota, the immune response, and insulin, TC, and TG concentrations. B-GOS may be a useful candidate for the enhancement of gastrointestinal health, immune function, and the reduction of metabolic syndrome risk factors in overweight adults.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3945/jn.112.166132

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vulevic, J., Juric, A., Tzortzis, G., & Gibson, G. R.
Affiliations
University of Reading (GB)
Corresponding author
Vulevic, Jelena
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2013-03
Volume
143
Issue
3
Pages
324-331
ISSN
0022-3166 (ISSN-L)
OpenAlex
W2145232186
Cited by
349
References
52
Citations by year
2026: 19 · 2025: 20 · 2024: 20 · 2023: 10 · 2022: 36 · 2021: 32 · 2020: 31 · 2019: 31 · 2018: 34 · 2017: 33 · 2016: 30 · 2015: 22 · 2014: 18 · 2013: 11
FWCI
24.96
Type
journal article
Language
en
Open access
Locations
  • Journal of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
Clasado Ltd
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
galactooligosaccharides, prebiotics, metabolic syndrome, overweight adults, gut microbiota, secretory IgA, calprotectin, C-reactive protein, inflammation, insulin, lipid metabolism, cholesterol, triglycerides, TC/HDL-C ratio, immune function
MeSH terms
Adult, Bacteria, Bifidobacterium, C-Reactive Protein, Double-Blind Method, Feces, Female, Galactose, Humans, Immunoglobulin A, Immunity, Inflammation, Insulin, Lipids, Male, Middle Aged, Oligosaccharides, Risk Factors, Biomarkers, Cross-Over Studies, Metabolic Syndrome, Leukocyte L1 Antigen Complex, Overweight, Metagenome, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review